Possible mechanisms for the effects of botulinum toxin on pain

被引:92
作者
Arezzo, JC
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA
[2] Yeshiva Univ Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA
关键词
D O I
10.1097/00002508-200211001-00003
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
The therapeutic effects of botulinum toxin are principally, if not exclusively, derived from an alteration in the release of acetylcholine (ACh) at pre-synaptic neurons. The rationale for how these effects could be beneficial in conditions characterized by excessive muscle contraction is clear, but the hypotheses regarding botulinum toxin-induced effects on pain are highly speculative. We explore five possible mechanisms by which botulinum toxin could directly or indirectly alter pain, including: 1) changes in the sensitivity and response patterns of group III and IV muscle nociceptors, 2) diminished activity in the gamma-motor neurons and consequent changes in muscle spindle afferents, 3) alterations in cholinergic control of vascular and autonomic functions, including neurogenic inflammation, 4) induced neuroplastic changes in the processing of afferent somatosensory activity at multiple levels of the neuroaxis, and 5) direct non-cholinergic effects on pain afferents.
引用
收藏
页码:S125 / S132
页数:8
相关论文
共 79 条
  • [1] AOKI KR, 2001, J NEUROL, V248
  • [2] AOKI R, 1998, PAIN DIGEST, V8, P337
  • [3] CHARACTERIZATION OF THE INHIBITORY-ACTION OF BOTULINUM NEUROTOXIN TYPE-A ON THE RELEASE OF SEVERAL TRANSMITTERS FROM RAT CEREBROCORTICAL SYNAPTOSOMES
    ASHTON, AC
    DOLLY, JO
    [J]. JOURNAL OF NEUROCHEMISTRY, 1988, 50 (06) : 1808 - 1816
  • [4] Experimental human muscle pain and muscular hyperalgesia induced by combinations of serotonin and bradykinin
    Babenko, V
    Graven-Nielsen, T
    Svensson, P
    Drewes, AM
    Jensen, TS
    Arendt-Nielsen, L
    [J]. PAIN, 1999, 82 (01) : 1 - 8
  • [5] Duration and distribution of experimental muscle hyperalgesia in humans following combined infusions of serotonin and bradykinin
    Babenko, V
    Svensson, P
    Graven-Nielsen, T
    Drewes, AM
    Jensen, TS
    Arendt-Nielsen, L
    [J]. BRAIN RESEARCH, 2000, 853 (02) : 275 - 281
  • [6] Berardelli A, 2002, SCI THERAPEUTIC ASPE, P171
  • [7] TETANUS TOXIN AND BOTULINUM-A TOXIN INHIBIT RELEASE AND UPTAKE OF VARIOUS TRANSMITTERS, AS STUDIED WITH PARTICULATE PREPARATIONS FROM RAT-BRAIN AND SPINAL-CORD
    BIGALKE, H
    HELLER, I
    BIZZINI, B
    HABERMANN, E
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1981, 316 (03) : 244 - 251
  • [8] SELECTIVE LOCATION OF ACCEPTORS FOR BOTULINUM NEUROTOXIN-A IN THE CENTRAL AND PERIPHERAL NERVOUS SYSTEMS
    BLACK, JD
    DOLLY, JO
    [J]. NEUROSCIENCE, 1987, 23 (02) : 767 - 779
  • [9] Botulinum toxin therapy for pain and inflammatory disorders: mechanisms and therapeutic effects
    Borodic, GE
    Acquadro, M
    Johnson, EA
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2001, 10 (08) : 1531 - 1544
  • [10] LOCALIZED INJECTIONS OF BOTULINUM TOXIN FOR THE TREATMENT OF FOCAL DYSTONIA AND HEMIFACIAL SPASM
    BRIN, MF
    FAHN, S
    MOSKOWITZ, C
    FRIEDMAN, A
    SHALE, HM
    GREENE, PE
    BLITZER, A
    LIST, T
    LANGE, D
    LOVELACE, RE
    MCMAHON, D
    [J]. MOVEMENT DISORDERS, 1987, 2 (04) : 237 - 254